Navigation Links
Leaders in Fight Against Cancer Join Historic Initiative to Address Critical Shortage of Clinical Investigators
Date:6/21/2011

gator Award program, which has made possible some of the most critical breakthroughs in oncology research of the last decade. Yervoy, a newly approved drug featured at the most recent meeting of the American Society of Clinical Oncology (ASCO), and the first treatment that improves overall survival in melanoma skin cancer patients, resulted from the clinical research of Dr. Jedd Wolchok, a previous Damon Runyon Clinical Investigator Awardee.  Since 2000, 58 outstanding physician-scientists have received these Damon Runyon awards; all of those scientists remain in clinical cancer research today. At least 17 of these scientists presented their work at ASCO 2011.

Future cancer breakthroughs require more support. Accelerating Cancer Cures will:

  • Fund the work of early career physician-scientists to meet the critical shortage of young scientists entering the clinical oncology research field.
  • Provide the investigators with access to the expertise of senior oncology executives and leaders in academic cancer research to help translate discoveries into therapeutic treatments.
  • Create opportunities for the investigators to collaborate with pharmaceutical and biotechnology companies and to learn about industry science as visiting scientists.
  • Foster collaboration between researchers by hosting an annual translational research summit that connects young scientists and leaders from industry and academia.

"The biopharmaceutical industry is committed to developing cancer cures fueled by partnerships with leading researchers in academia. Key oncology breakthroughs of the coming decade will arise from this type of collaborative scientific research," said Richard Gaynor, M.D., Vice President of Product Development and Medical Affairs at Lilly Oncology. "Damon Runyon's prestigious track record of identifying and supporting talent makes them the natural leader for this effort. Accelerating Can
'/>"/>

SOURCE Damon Runyon Cancer Research Foundation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. BIOSCIENCE EAST, the Life Sciences Industry Map, Highlighting Global Leaders in Healthcare Innovation, Kicks Off 5th Edition
2. CIO magazine Honors Life Technologies for Leadership in Information Technology
3. LABSCO Strengthens Executive Leadership Team
4. BioStorage Technologies, Inc. Brings Together Industry Leaders to Discuss Future Trends and Challenges of Global Biobanking Community
5. Stereotaxis Continued Leadership in Scientific Outcome Data Prominently Displayed with Multiple Key Presentations at HRS 2011
6. Congressional Leaders Urge HHS Secretary to Approve Coding for Advanced Lower Limb Prosthetic Device, Smart Pyramid™
7. International Leaders in Electrophysiology Discuss Improving Atrial Fibrillation Treatment Using Novel Endoscopically Guided Laser Ablation Catheter
8. Prime Therapeutics President and CEO Eric Elliott Delivers Speech at University of Minnesota College of Pharmacy Dialogues in Managed Care Leadership 2011
9. National Leaders in Emergency Medicine and Patient Safety to Address Future Opportunities and Challenges in Emergency Care
10. Worlds Leaders on Macular Disease Convene in New York on April 16 for AMD Alliance International (AMDAI) Meeting
11. Cepheid Extends Rapid Molecular Diagnostics Leadership with FDA Clearance of Xpert Clostridium difficile/Epi
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/19/2014)... INDIANAPOLIS and LYON, France ... (NYSE: LLY ) and Adocia (Euronext Paris: ... focused on developing an ultra-rapid insulin, known as BioChaperone ... type 2 diabetes. BioChaperone Lispro relies on Adocia,s proprietary ... Lilly and Adocia will develop BioChaperone Lispro ...
(Date:12/17/2014)... and SAN DIEGO , Dec. 17, 2014 ... ; AEX: PHIA) and Volcano Corporation (NASDAQ: VOLC ... for cardiovascular applications, today announced that they have entered into ... commence a tender offer to acquire all of the issued ... or a total equity purchase price of USD 1 billion ...
(Date:12/17/2014)... -- Revenue and earnings above the previous year ... In the past 2013/14 fiscal year (ended 30 ... EUR 4.287 billion (last year: EUR 4.190 billion) despite unfavorable ... 360 million. "Overall, 2013/14 was a successful fiscal year for ... and CEO of Carl Zeiss AG. "Thanks to our broad ...
Breaking Medicine Technology:Lilly and Adocia Announce Alliance to Co-Develop Ultra-Rapid Insulin Based on BioChaperone Technology 2Lilly and Adocia Announce Alliance to Co-Develop Ultra-Rapid Insulin Based on BioChaperone Technology 3Philips to acquire Volcano to expand global leadership position in image-guided therapy market 2Philips to acquire Volcano to expand global leadership position in image-guided therapy market 3Philips to acquire Volcano to expand global leadership position in image-guided therapy market 4Philips to acquire Volcano to expand global leadership position in image-guided therapy market 5Philips to acquire Volcano to expand global leadership position in image-guided therapy market 6Philips to acquire Volcano to expand global leadership position in image-guided therapy market 7Philips to acquire Volcano to expand global leadership position in image-guided therapy market 8ZEISS Asserts its Position in Difficult Environment 2
... May 1 Older adults can improve memory and attention ... presented today at the annual meeting of the American Geriatrics ... study and a professor at the University of Southern ... gains persist months after the training ended.A total of 487 ...
... April 30 SpectraScience, Inc. (OTC Bulletin Board: SCIE) ... Iowa,s Des Moines Register published an article reporting that its LUMA ... the University of Iowa . Since Last July, researchers ... have used the LUMA Cervical Imaging System in more ...
Cached Medicine Technology:Brain Training Improves Memory and Attention and the Effects Last 2Des Moines Register Reports SpectraScience LUMA Enhances Cervical Cancer Exams 2Des Moines Register Reports SpectraScience LUMA Enhances Cervical Cancer Exams 3
(Date:12/19/2014)... 2014 Today, Balfleet.com , a ... announces its formal dress promotion. All the old and ... 60% off. , Balfleet.com is well-known for its high ... prom dresses, cocktail dresses and more. Its formal dresses ... guarantee, and they can create an elegant look when ...
(Date:12/19/2014)... 19, 2014 Energy Textiles is ... now available. Celliant, the world’s leading responsive textile, ... pillowcases. , There are a number of benefits ... increased oxygenation and balanced body temperature; which can ... pain relief; enhanced athletic performance; and overall wellness. ...
(Date:12/19/2014)... OK (PRWEB) December 19, 2014 Eufaula, ... home to Lake Eufaula, the state’s largest lake with ... lakeside town is home to a little more than ... 1:00 P.M. on Saturday, the 6th of December. , ... its way through downtown Eufaula on Main Street. ...
(Date:12/19/2014)... December 20, 2014 The print component ... and Business subscription of the Toronto Star, with a ... of 622,169. The digital component is distributed nationally through ... of top news sites and partner outlets. To explore ... . , The publication features an exclusive interview ...
(Date:12/19/2014)... 2014 (HealthDay News) -- Potentially illness-causing E. coli bacteria ... farmers markets, according to a new study. Researchers ... from 13 farmers markets in Los Angeles and Orange ... of almost 150 samples tested, 24 percent were positive ... according to the researchers. Both types of bacteria ...
Breaking Medicine News(10 mins):Health News:Balfleet.com Announces Its Formal Dress Promotion For 2015 2Health News:Energy Textiles Launches Celliant Revitalizing Bedsheets 2Health News:Narconon Arrowhead Debuts Float at Checotah and Eufaula Christmas Parades 2Health News:Narconon Arrowhead Debuts Float at Checotah and Eufaula Christmas Parades 3Health News:Mark DeMontis, Founder of Courage Canada, shares his passion for bringing hockey to those affected by blindness in Mediaplanet’s “Vision and Hearing” campaign 2Health News:E. Coli Germs Found on Farmers Market Herbs 2
... their opinion- Nature’s way is far superior to pre-planned caesarian ... of it being unnecessary. , According to their ... encountered by a woman who opts for a C-section, in ... higher than that of a woman undergoing natural delivery. ...
... Researchers at UT Southwestern Medical Center have found that ... ,"We have discovered that C-Reactive Protein (CRP) ... hypertension, it actually induces hypertension," said Dr. Wanpen Vongpatanasin, ... the study appearing in the February issue of Circulation. ...
... PhD, published the first results showing that a biological phenomenon ... Since then he has used RNAi gene therapy to effectively ... mice. ,With three human RNAi gene therapy trials ... in RSV pneumonia - the technique Kay pioneered may be ...
... By first probing the way primitive yeast make ... long-sought protein whose human// counterpart controls cholesterol production ... study by investigators at Johns Hopkins University School ... Lilly Co., was published in the February issue ...
... Diabetes case management that takes a patient’s specific ... and decrease the incidence of diabetes-related complications over ... ,"Better management results in reduced long-term complications, ... said lead researcher Todd Gilmer, Ph.D. ...
... Jumping on a garden trampoline is a fun form of ... for children and youths// than traffic, according to a new ... of concern "especially due to neck and head injuries" that ... northern Sweden told the Svenska Dagbladet newspaper. ,The ...
Cached Medicine News:Health News:C-Reactive Protein Induces Hypertension 2Health News:RNAi Shows Promise in Gene Therapy 2Health News:Primitive Yeast Yields Secrets Of Human Cholesterol And Drug Metabolism 2Health News:Culturally Specific Diabetes Management Helps Low-Income Patients 2
VascoScrew is a unipolar permanent pacing lead with a fixed screw a double flanch for permanent pacing. Due to latest technologies, VascoScrew D10/60 M is compatible to all pacemaker-cavities with th...
VascoScrew is a low profile unipolar pacing lead with a fixed screw for permanent pacing. Due to latest technologies, VascoScrew 6/60 M is compatible to all pacemaker-cavities with the size of IS-1 (...
VascoScrew is a low profile unipolar pacing lead with a fixed screw for permanent pacing. Due to latest technologies, VascoScrew 6/60 M is compatible to all pacemaker-cavities with the size of IS-1 (...
VascoScrew is a low profile unipolar pacing lead with a fixed screw for permanent pacing. Due to latest technologies, VascoScrew 6/60 M is compatible to all pacemaker-cavities with the size of IS-1 (...
Medicine Products: